Rare diseases
Investigational molecules
Locations
Back to Norway123 clinical trials in Loerenskog, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
NorwayStudy of MK-3120 for patients with high-risk non-muscle invasive bladder cancer who have not received or have received BCG treatment
NorwayStudy of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups
NorwayStudy on the Effects of CAL101 for Patients with Idiopathic Pulmonary Fibrosis
NorwayStudy to Test if Nerandomilast (BI 1015550) Helps Patients with Interstitial Lung Disease Related to Rheumatic Diseases
NorwayStudy on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis
NorwayStudy on the Safety and Tolerability of Norucholic Acid Tablets for Patients with Primary Sclerosing Cholangitis (PSC)
NorwayStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
NorwayStudy Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
NorwayStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
NorwayStudy on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NorwayStudy on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis
NorwayThe busiest research cities in the country
What the registry says about research in the country
Research focusing on pulmonary diseases including trials for new treatments in idiopathic pulmonary fibrosis and COPD. Studies evaluating innovative therapies for chronic wet cough in children and investigating respiratory complications in systemic autoimmune conditions.
Advanced clinical research examining both medication efficacy and symptom management approaches.
Comprehensive studies on inflammatory bowel diseases, including trials for Ulcerative Colitis and Crohn's Disease. Research extends to liver conditions like Primary Sclerosing Cholangitis and colorectal cancer treatments.
Innovative approaches focusing on long-term disease management and diagnostic advancement.
Groundbreaking trials in hematological malignancies and solid tumors, including studies on chronic lymphocytic leukemia, lung cancer, and mesothelioma. Focus on combination therapies and targeted treatments.
Advanced therapeutic approaches combining immunotherapy with conventional treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
